Global Pediatric Vaccine Market 2014-2018

小児用ワクチンの世界市場

◆タイトル:Global Pediatric Vaccine Market 2014-2018
◆商品コード:IRTNTR4395
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2014年10月22日
◆ページ数:85
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Five UserUSD2,800 ⇒換算¥316,400見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは、"小児用ワクチンの世界市場"について調査・分析し、エグゼクティブサマリー、市場概観、市場規模及び予測、製品別分析、投与経路(ROA)別分析、主要地域別分析、主要国別分析、市場シェア、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析等の情報をお届けいたします。

About Pediatric Vaccines
Pediatric vaccines are used for the immunization of children and adolescents against various infectious diseases, such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases. According to the US FDA, pediatric age ranges are classified as newborn, infant, child, and adolescent, ranging from birth to 21 years. However, the EMA classifies pediatric age range from birth to 18 years.

TechNavio’s analysts forecast the Global Pediatric Vaccine market to grow at a CAGR of 10.25 percent over the period 2013-2018.

[Covered in this Report]
This report covers the present scenario and the growth prospects of the Global Pediatric Vaccine market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various approved vaccines.

TechNavio’s report, the Global Pediatric Vaccine Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Pediatric Vaccine market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• GlaxoSmithKline
• Merck
• Pfizer
• Sanofi

[Other Prominent Vendors]
• AstraZeneca
• Bavarian Nordic
• Baxter
• Bharat Biotech
• Bharat Immunologicals and Biologicals
• bioCSL
• Bio Med
• Crucell
• Dynavax Technologies
• Indian Immunologicals
• Janssen
• Kaketsuken
• LG Life Sciences
• Lupin
• Mitsubishi Tanabe Pharma
• Novartis
• Nuron
• Panacea Biotec
• Serum Institute of India
• Shenzhen Kangtai Biological Products
• Sinovac Biotech
• S K Chemicals
• Takeda Pharmaceutical
• Valeant Pharmaceuticals
• Zydus Cadila

[Market Driver]
• Inclusion in National Immunization Schedule
• For a full, detailed list, view our report

[Market Challenge]
• Inadequate Vaccine Coverage
• For a full, detailed list, view our report

[Market Trend]
• Increase in Strategic Alliances
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Route of Administration
07.1 Oral
07.2 Parenteral
08. Market Segmentation by Product Type
08.1 Polysaccharide Vaccines
08.2 Conjugate Vaccines
09. Geographical Segmentation
09.1 Pediatric Vaccine Market in Americas
09.1.1 Market Size and Forecast
09.1.2 Pediatric Vaccine Market in US
09.1.3 Pediatric Vaccine Market in Latin America
09.2 Pediatric Vaccine Market in EMEA
09.2.1 Market Size and Forecast
09.2.2 Pediatric Vaccine Market in Europe
09.3 Pediatric Vaccine Market in APAC
09.3.1 Market Size and Forecast
09.3.2 Pediatric Vaccine Market in China
09.3.3 Pediatric Vaccine Market in India
09.3.4 Pediatric Vaccine Market in Japan
10. Key Leading Countries
10.1 US
10.2 China
10.3 India
10.4 Japan
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2013
18.2.1 GlaxoSmithKline
18.2.2 Sanofi
18.2.3 Pfizer
18.2.4 Merck
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 GlaxoSmithKline
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation
19.1.4 Business Segmentation by Revenue 2012 and 2013
19.1.5 Sales by Geography
19.1.6 Pipeline Products
19.1.7 Business Strategy
19.1.8 Key Information
19.1.9 SWOT Analysis
19.2 Merck & Co. Inc.
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Segmentation by Revenue 2013
19.2.4 Business Segmentation by Revenue 2012 and 2013
19.2.5 Sales by Geography
19.2.6 Business Strategy
19.2.7 Key Developments
19.2.8 SWOT Analysis
19.3 Pfizer Inc.
19.3.1 Key Facts
19.3.2 Business Description
19.3.3 Business Segmentation
19.3.4 Revenue by Business Segmentation
19.3.5 Revenue Comparison 2012 and 2013
19.3.6 Sales by Geography
19.3.7 Business Strategy
19.3.8 Key Developments
19.3.9 SWOT Analysis
19.4 Sanofi
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation by Revenue 2013
19.4.4 Business Segmentation by Revenue 2012 and 2013
19.4.5 Geographical Segmentation by Revenue 2013
19.4.6 Business Strategy
19.4.7 Key Developments
19.4.8 SWOT Analysis
20. Other Reports in this Series

[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Global Pediatric Vaccine Market 2013-2018 (US$ billion)
Exhibit 3: Global Pediatric Vaccine Market Segmentation by Route of Administration
Exhibit 4: Global Pediatric Vaccine Market by Route of Administration 2013
Exhibit 5: Global Pediatric Vaccine Market Segmentation by Product Type
Exhibit 6: Global Pediatric Vaccine Market Segmentation by Product Type 2013
Exhibit 7: Global Pediatric Vaccine Market by Geographical Segmentation 2013
Exhibit 8: Global Pediatric Vaccine Market by Region/Country 2013
Exhibit 9: Pediatric Vaccine Market in Americas by Region/Country 2013
Exhibit 10: Pediatric Vaccine Market in Americas by Region/Country 2018
Exhibit 11: Pediatric Vaccine Market in Americas 2013-2018 (US$ billion)
Exhibit 12: Pediatric Vaccine Market in the US 2013-2018 (US$ billion)
Exhibit 13: Pediatric Vaccine Market in Latin America 2013-2018 (US$ billion)
Exhibit 14: Pediatric Vaccine Market in EMEA by Region 2013
Exhibit 15: Pediatric Vaccine Market in EMEA by Region 2018
Exhibit 16: Pediatric Vaccine Market in EMEA 2013-2018 (US$ billion)
Exhibit 17: Pediatric Vaccine Market in Europe 2013-2018 (US$ billion)
Exhibit 18: Pediatric Vaccine Market in APAC by Region 2013
Exhibit 19: Pediatric Vaccine Market in APAC by Region 2018
Exhibit 20: Pediatric Vaccine Market in APAC 2013-2018 (US$ billion)
Exhibit 21: Pediatric Vaccine Market in China 2013-2018 (US$ billion)
Exhibit 22: Pediatric Vaccine Market in India 2013-2018 (US$ billion)
Exhibit 23: Pediatric Vaccine Market in Japan 2013-2018 (US$ billion)
Exhibit 24: Comparison of Global Vaccine Market to Global Pediatric Vaccine Market 2013
Exhibit 25: Global Pediatric Vaccine Market Share Analysis 2013
Exhibit 26: GlaxoSmithKline’s Revenue 2013
Exhibit 27: Sanofi’s Revenue 2013
Exhibit 28: Pfizer’s Revenue 2013
Exhibit 29: Merck’s Revenue 2013
Exhibit 30: GlaxoSmithKline: Business Segmentation 2013
Exhibit 31: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 32: GlaxoSmithKline: Sales by Geography 2013
Exhibit 33: GlaxoSmithKline: Pipeline Products 2013
Exhibit 34: Merck & Co. Inc.: Business Segmentation by Revenue 2013
Exhibit 35: Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 36: Merck & Co. Inc.: Sales by Geography 2013
Exhibit 37: Pfizer Inc.: Business Segmentation
Exhibit 38: Pfizer Inc.: Revenue by Business Segmentation 2013
Exhibit 39: Pfizer Inc.: Revenue by Business Segmentation 2012 and 2013
Exhibit 40: Pfizer Inc.: Revenue by Geography 2013
Exhibit 41: Sanofi: Business Segmentation by Revenue 2013
Exhibit 42: Sanofi: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 43: Sanofi: Geographical Segmentation by Revenue 2013



【掲載企業】

GlaxoSmithKline,Merck,Pfizer,Sanofi ,AstraZeneca,Bavarian Nordic,Baxter,Bharat Biotech,Bharat Immunologicals and Biologicals ,bioCSL,Bio Med,Crucell,Dynavax Technologies,Indian Immunologicals,Janssen ,Kaketsuken,LG Life Sciences,Lupin,Mitsubishi Tanabe Pharma,Novartis,Nuron ,Panacea Biotec,Serum Institute of India,Shenzhen Kangtai Biological Products ,Sinovac Biotech,S K Chemicals,Takeda Pharmaceutical ,Valeant Pharmaceuticals,Zydus Cadila

【資料のキーワード】

小児用ワクチン、ジフテリアワクチン、インフルエンザワクチン、肝炎ワクチン、肺炎球菌ワクチン、髄膜炎菌ワクチン

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[小児用ワクチンの世界市場] (Global Pediatric Vaccine Market 2014-2018 / IRTNTR4395)販売に関する免責事項
[小児用ワクチンの世界市場] (Global Pediatric Vaccine Market 2014-2018 / IRTNTR4395)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆